Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients

NCT02158910 is registered in ClinicalTrials.gov with Eisai Korea Inc. as lead sponsor.

NCT NCT02158910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02158910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Plan on Investigation and Collection of Aricept Safety Information With a Dose Increase on Alzheimer's Disease Patients
Lead sponsor
Eisai Korea Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2015
Completion date
June 30, 2016
Enrollment
2,231 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease